Home Forums |
|
Drugs and Drug Treatments ATG, Cyclosporine, Revlimid, Vidaza, Dacogen, ... |
|
Thread Tools | Search this Thread |
#276
|
|||
|
|||
We're Out of Here!
Hi All!
Well, it's been a good run, but I think it's time we closed down this Campath roadshow and moved on to greener pastures. Dr. Olnes' evaluation of my latest BMB is that response is unlikely at this late date; and, given my every other week transfusion schedule, it's time to try something new. A new therapy requires a new thread, no? So come look for me here, where I'm crowd sourcing my next therapy. I need your help researching my options. Take Care! Greg
__________________
Greg, 59, dx MDS RCMD Int-1 03/10, 8+ & Dup1(q21q31). NIH Campath 11/2010. Non-responder. Tiny telomeres. TERT mutation. Danazol at NIH 12/11. TX independent 7/12. Pancreatitis 4/15. 15% blasts 4/16. DX RAEB-2. Beginning Vidaza to prep for MUD STC. Check out my blog at www.greghankins.com |
#277
|
|||
|
|||
Hi Greg,
I can't add any insight, you are way ahead of me already. I'll also be interested in Dr. Olnes take. Blasts not worth mentioning, wow! And crowd sourcing? Did you invent that??
__________________
Catherine, wife of Bruce age 75; diagnosed 6/10/11 with macrocytic anemia, neutropenia and mild thrombocytopenia; BMB suggesting emerging MDS. Copper deficient. Currently receiving procrit and neuopogen injections weekly, B12 dermal cream and injections, Transfusions ~ 5 weeks. |
#278
|
|||
|
|||
Hey Catherine!
I cannot take credit for crowd sourcing; I'm not sure who came up with that one. Dr. Olnes opined that my disappearing Trisomy 8 could be the result of the Campath, but, given my increased need for RBC transfusions, he doesn't expect further response. His first line recommendation is Revlimid, though I've asked him about ezatiostat, as well. So I'm in the hunt from promising new therapies for low-risk folks. Have a great Sunday! Greg
__________________
Greg, 59, dx MDS RCMD Int-1 03/10, 8+ & Dup1(q21q31). NIH Campath 11/2010. Non-responder. Tiny telomeres. TERT mutation. Danazol at NIH 12/11. TX independent 7/12. Pancreatitis 4/15. 15% blasts 4/16. DX RAEB-2. Beginning Vidaza to prep for MUD STC. Check out my blog at www.greghankins.com |
#279
|
|||
|
|||
Hi Greg,
I have a question for you...How long after Campath is your CD4/CD8 ratio expected to be reversed? Could it be reversed because you still have some kind of auto immune attack going on in your system?
__________________
58 yo female, dx 9/08, AA/hypo-MDS, subclinical PNH, ATG/CsA 12/08, partial response. small trisomy 6 clone, low-dose cyclosporine dependent |
#280
|
|||
|
|||
Hi Hopeful!
Dr.Olnes tells me that the Campath-induced CD4/CD8 inversion lasts about two years. I gather that Campath knocks down lots of different T-cells and B-cells, but maybe knocks down the CD4s even more than the rest. Near as I can tell, it's an expected effect of the drug. Take care! Greg
__________________
Greg, 59, dx MDS RCMD Int-1 03/10, 8+ & Dup1(q21q31). NIH Campath 11/2010. Non-responder. Tiny telomeres. TERT mutation. Danazol at NIH 12/11. TX independent 7/12. Pancreatitis 4/15. 15% blasts 4/16. DX RAEB-2. Beginning Vidaza to prep for MUD STC. Check out my blog at www.greghankins.com |
Thread Tools | Search this Thread |
|
|
Similar Threads | ||||
Thread | Thread Starter | Forum | Replies | Last Post |
Pilot study of Alemtuzumab (Campath) at NIH | Barbara2007 | Clinical Trials | 9 | Thu May 5, 2022 12:38 AM |
New Promacta (Eltrombopag) Clinical Trial at NIH | Sally C | Clinical Trials | 73 | Sun Dec 30, 2018 05:52 AM |
NIH Trial - Plt Count Level Feedback/Experience | disco3md | AA | 1 | Wed Jun 28, 2017 01:08 PM |
NIH Trial (Eltrombopag & Cyclosporine) | disco3md | Clinical Trials | 0 | Mon Jun 26, 2017 05:02 PM |
Subcutaneous Campath Trial | Nadia T | Clinical Trials | 3 | Fri Dec 20, 2013 09:06 PM |